Skip to main content
. Author manuscript; available in PMC: 2022 Oct 14.
Published in final edited form as: Am J Med Genet C Semin Med Genet. 2021 Nov 7:10.1002/ajmg.c.31939. doi: 10.1002/ajmg.c.31939

Table 3:

Logistic odds of having vulvodynia based on the presence of comorbid conditions common in Ehlers-Danlos syndromes (and hypermobility spectrum disorders) and vulvodynia (p=0.000).

Variable N Adjusted OR 95% Cl P
Age 1146 0.984 0.974 – 0.995 0.003*
US Resident 1146 0.639 0.476 – 0.858 0.002*
Temporomandibular Joint Dysfunction 651 1.286 1.008 – 1.639 0.043*
Fibromyalgia 463 1.885 1.457 – 2.416 0.000*
Migraine Headaches 78 1.548 0.939 – 2.554 0.087
Mast Cell Activation Syndrome 118 0.928 0.622 – 1.384 0.714
Interstitial Cystitis 19 5.652 1.607 – 19.883 0.007*
Irritable Bowel Syndrome 75 0.632 0.381 – 1.048 0.075
*

significant findings at p< .05 level